熱門資訊> 正文
Inventiva宣布以1.25亿美元在美国公开发行美国存托凭证
2025-11-13 05:42
- Inventiva (IVA) plans to offer ~$125 American Depositary Shares.
- Each ADS will represent one new ordinary share of the company.
- The underwritten public offering will be conducted in the United States only.
- All securities in the offering will be sold by Inventiva itself.
- Proceeds will support the NATiV3 Phase 3 clinical trial, preparation of an outcome trial, and commercialization efforts, as well as working capital and general corporate purposes.
More on Inventiva S.A
- Inventiva S.A. (IVA) Analyst/Investor Day - Slideshow
- Inventiva S.A. (IVA) Analyst/Investor Day Transcript
- MASH drug developers rise as FDA accepts lenient trial requirement
- Inventiva surges as Piper Sandler issues bullish view citing lead asset
- Seeking Alpha’s Quant Rating on Inventiva S.A
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。